Inventor · disambiguated record
Konstantinos Lioumis
Also filed as: LIOUMIS KONSTANTINOS · LIOUMIS KONSTANTINOS I
7 granted patents·4 pending applications·12 citations·filing 2004–2025
76Inventor score
Technology areasA61K
Files withPHARMA DATA RES AND DEVELOPMENT SINGLE MEMBER S A4EMP LEVO US B V2AUTHENDA PHARMACEUTICALS AG1HYLORIS DEV SA1KARAVAS EVANGELOS1
Top patents by PatentIndex Score
11 records- 0182US9050307B2Method for the preparation of a levothyroxine solutionPSARRAKIS YANNIS·Filed 2011·Granted Jun 9, 2015·10 cites·15 claims
- 0277US11096915B2Methods for the preparation of a levothyroxine solutionEMP LEVO US B V·Filed 2017·Granted Aug 24, 2021·2 cites·18 claims
- 0375US12295953B2Oral gliptin compositions and method for preparation thereofPHARMA DATA RES AND DEVELOPMENT SINGLE MEMBER S A·Filed 2024·Granted May 13, 2025·0 cites·22 claims
- 0467US2025302828A1Oral gliptin compositions and method for preparation thereofPHARMA DATA RES AND DEVELOPMENT SINGLE MEMBER S A·Filed 2025·Application pending·0 cites
- 0563US12214075B2Apixaban suspension and preparation methodPHARMA DATA RES AND DEVELOPMENT SINGLE MEMBER S A·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 0661US12213954B2Colchicine solutionPHARMA DATA RES AND DEVELOPMENT SINGLE MEMBER S A·Filed 2022·Granted Feb 4, 2025·0 cites·21 claims
- 0761US11938109B2Methods for the preparation of a levothyroxine solutionEMP LEVO US B V·Filed 2021·Granted Mar 26, 2024·0 cites·24 claims
- 0858US11944621B2Oral gliptin compositions and method for preparation thereofAUTHENDA PHARMACEUTICALS AG·Filed 2020·Granted Apr 2, 2024·0 cites·18 claims
- 0958US2006182797A1Sutained release formulation for venlafaxine hydrochlorideKARAVAS EVANGELOS·Filed 2004·Application pending·0 cites
- 1050US2011171297A1Sustained release formulation for venlafaxine hydrochloridePHARMATHEN SA·Filed 2011·Application pending·0 cites
- 1145US2019216823A1Methylprednisolone pharmaceutical suspensionHYLORIS DEV SA·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Konstantinos Lioumis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →